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Abstract
Background: Congenital cryptorchidism, i.e. failure of the testicular descent to the bottom of the scrotum, is a
common birth defect. The evidence from epidemiological, wildlife, and animal studies suggests that exposure to
mixtures of endocrine disrupting chemicals during fetal development may play a role in its pathogenesis. We aimed
to assess the association between cryptorchidism and prenatal exposure to polychlorinated biphenyls (PCBs),
polychlorinated dibenzo-p-dioxins and furans (PCDD/Fs), and polybrominated diphenyl ethers (PBDEs).
Methods: We conducted a case–control study consisting of 44 cryptorchid cases, and 38 controls operated for inguinal
hernia, umbilical hernia, or hydrocele at the Turku University Hospital or Rigshospitalet, Copenhagen in 2002–2006. During
the operation a subcutaneous adipose tissue biopsy was taken. Samples were analysed for 37 PCBs, 17 PCDD/Fs and 14
PBDEs by gas chromatography-high-resolution mass spectrometry. Chemical concentrations were adjusted for postnatal
variation introduced by differences in duration of breastfeeding, age at the operation, and country of origin with
a multiple linear regression. Association between adjusted and unadjusted chemical concentrations and the risk
of cryptorchidism were analysed with logistic regression to get an estimate for odds ratio (OR) of cryptorchidism
per multiplication of chemical concentrations with ca. 2.71 (Napier’s constant).
Results: Total-TEq i.e. the WHO-recommended 2,3,7,8-TCDD equivalent quantity of 17 dioxins and 12 dioxin-like
PCBs and sum of PCDD/Fs were positively associated with cryptorchidism [OR 3.21 (95 % CI 1.29–9.09), OR 3.69
(95 % CI 1.45–10.9), respectively], when adjusting for country of origin, the duration the child was breastfed, and
age at operation. The association between the sum of PCBs and cryptorchidism was close to significant [OR 1.92
(95 % CI 0.98–4.01)], whereas the association between the sum of PBDEs and cryptorchidism was not [OR 0.86
(95 % CI 0.47–1.54)]. There were no associations between unadjusted chemical concentrations and the risk of
cryptorchidism.
Conclusions: Prenatal exposure to PCDD/Fs and PCDD/F-like PCBs may be associated with increased risk for
cryptorchidism. Our finding does not exclude the possibility of an association between the exposure to PBDEs
and cryptorchidism.
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Introduction
According to prospective cohort studies, congenital crypt-
orchidism i.e. failure of the testicular descent to the bottom
of the scrotum is found in 1.8–8.4 % of mature new-born
boys [1]. It is a well-established risk factor for testicular
cancer and is associated with compromised fertility [2, 3].
The incidence of congenital cryptorchidism has apparently
increased in Denmark and the UK according to prospective
cohort studies using similar diagnostic criteria [4, 5]. Based
on epidemiological, experimental, and wildlife evidence,
recently reviewed by the UNEP/WHO expert panel [6],
it has been hypothesised that the prenatal exposure to
anti-androgenic endocrine disrupting chemicals might
be causally related to congenital cryptorchidism [7]. Further
research in animal models suggests that the developing
male fetus is especially susceptible to the anti-androgenic
effects during 8–14 weeks of gestation when the develop-
ment of the male reproductive tract appears to be
programmed [8].
Persistent organic pollutants are a group of potential
endocrine disrupting chemicals that are toxic, persist-
ent, able to bioaccumulate, and move long distances by
natural processes in soil, water, air, and biota [6]. This
group includes intentionally produced chemicals such
as polychlorinated biphenyls (PCBs) that were banned
in the mid-1980s and polychlorinated dibenzo-p-dioxins
and dibenzofurans (PCDD/Fs or “dioxins”), which are unin-
tentionally produced during combustion and industrial pro-
cesses [6, 9]. Unlike these two persistent organic pollutants,
some polybrominated diphenyl ether (PBDE) congeners are
still actively produced and used as flame-retardants in
electrical devices, furniture, and textiles [6]. US citizens
are substantially more exposed to PBDEs compared to
Europeans, very likely due to differences in the fire safety
standards [10].
In Northern Europe, exposure studies show declining
body burdens of PCBs and PCDD/Fs after the 1980s
whereas the body burden of PBDEs kept increasing rapidly
until the early 2000s [11, 12]. Today, humans are exposed
to PCBs, PCDD/Fs, and PBDEs via breastfeeding and con-
sumption of fish, meat, and dairy products [13–15], and to
PBDEs also via inhalation and ingestion of indoor dust [16].
PCBs, PCDD/Fs, and PBDEs are excreted to lipid-rich
breast milk, and the exposure per kilogram body weight
is high during lactation and in toddlers [14, 16].
In experimental studies with laboratory animals, there
is evidence of adverse changes in the reproductive system
of the offspring after maternal exposure to PCBs, PCDD/Fs
and PBDEs [17–21], including some reports that maternal
exposure to PCBs and PCDD/Fs, but not to PBDEs, may
disrupt or delay testicular descent [22–25]. An occupational
study suggested already in 1996 that the exposure of male
sawmill workers to PCDD/F-contaminated chlorophenol
was associated with congenital cryptorchidism in their male
offspring [26]. In addition, previous epidemiological studies
suggested a relatively weak association between crypt-
orchidism and levels of PCBs, PCDD/Fs, and PBDEs in
breast milk [27–29]. However, other studies examining
maternal serum, placenta, umbilical cord or cord blood,
which have smaller lipid content, did not observe the same
associations [28–32]. In two of our previous studies, we
also observed a positive correlation between serum LH
levels and the exposure to PCBs and PBDEs, suggesting a
subtle effect on testicular Leydig cell function [28, 30].
As a lipid-rich matrix, adipose tissue provides a good
alternative for examining these fat-soluble persistent
organic pollutants in the child. The lipid-adjusted con-
centrations of persistent organic pollutants appear to
be similar between serum and adipose tissue [33], but
the serum levels appear to have a higher day-to-day vari-
ation due to dietary exposure to persistent organic pollut-
ants [34]. Furthermore, due to high lipid content in adipose
tissue, concentrations of these chemicals can be detected
from adipose tissue at the level that would require high vol-
umes of blood to be drawn from the small child. In con-
trast, if the child is operated for a medical condition, fat
tissue biopsies can be taken during the operation without
further risk or distress to the child. To our knowledge, only
one study has examined the association between crypt-
orchidism and the levels of various persistent organic
pollutants in the adipose tissue; Hosie et al. found that
the concentrations of heptachloroepoxides and hexachlor-
obenzenes, but not PCBs, were higher in cryptorchid boys
than in controls [35]. However, some of the subjects in
that study were more than 10 years old, which increases
the postnatal exposure, and therefore decreases the likeli-
hood of observing a difference between groups.
To assess the association between congenital cryptorchi-
dism and exposure to PCBs, PCDD/Fs and PBDEs during
pregnancy, we carried out a non-matched cross-sectional
case–control study comparing the levels of PCBs, PCDD/
Fs and PBDEs between boys operated for cryptorchidism
and for inguinal hernia, abdominal hernia or hydrocele.
Adipose tissue concentrations of PCBs, PCDD/Fs, and




The participants were recruited from the children
operated in the Departments of Paediatric Surgery in
Turku University Hospital, Turku, Finland (2002–2006)
and Rigshospitalet, Copenhagen, Denmark (2004–2005).
In Finland, children under 5 years of age were included.
In Denmark, there were no age limitations, but parents
and grandparents of the child had to be born and raised
in Denmark and not have lived abroad for more than
3 years (mother) or 10 years (rest of the family). Although
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there were no limitations considering ethnicity in the
Finnish study, all participants were of Finnish origin.
Thirty-five Finnish and 14 Danish boys who were sched-
uled for orchidopexy of one or both testes by a paediatric
surgeon were included as cases. Five of the Finnish cases
were excluded from the study when no testis was found at
operation. Twelve of the Finnish and two of the Danish
cases were referred to orchidopexy from a prospective
study to assess the prevalence of congenital cryptorchid-
ism [5]. Twenty-seven Finnish boys who were operated
for inguinal hernia, one for abdominal hernia, and one for
hydrocele, and nine Danish boys who were operated for
inguinal hernia were recruited as controls. During the op-
eration, a subcutaneous adipose tissue biopsy was taken
from the incision area and samples were frozen. The loca-
tion of the biopsy was same both among cases and
controls.
Main outcome measures were sums of 37 PCBs, 17
PCDD/Fs, 14 PBDEs, and total-TEq, i.e. WHO-recom
mended 2,3,7,8-TCDD equivalent quantity of 17 dioxins
and 12 dioxin-like PCBs, in adipose tissue. The TEq value
was calculated by multiplying the concentration of each
congener with a toxic equivalency factor [36], and sum-
ming up all equivalents.
Before the operation, the parents of the Finnish subjects
were asked to answer a questionnaire how many months
the child was breastfed exclusively, the age when the breast-
feeding was discontinued, and the total number of months
the mother had breastfed her previous children. Obstetric
data of 28 Finnish cases and 22 controls (maternal smok-
ing, gestational diabetes, length of gestation, mother’s
weight before pregnancy, birth weight, parity) were ob-
tained from medical records, while data of two cases and
seven controls were not available. If maternal smoking or
gestational diabetes were not mentioned in the medical re-
cords, the mother was assumed to be a non-smoker and/or
without gestational diabetes. Danish versions of the ques-
tionnaire that additionally contained questions on length of
gestation, gestational diabetes, and birth weight were
mailed to the parents of the subjects in 2013, and those
who did not answer were contacted via telephone and
interviewed. The Danish subjects were not asked about
the occurrence of maternal smoking. Three Danish cases
and one control answered to neither mailed questionnaire
nor telephone call. Altogether 24 cases (nine Danish,
15 Finnish) and 28 (eight Danish, 20 Finnish) controls
had all the background data available except for mater-
nal smoking.
Ethics statement
The study was performed according to the Helsinki II
declaration and approved by the Joint Ethics Committee
of the University of Turku and Turku University Hospital,
the Local Danish Ethics committee and the Danish Data
Protection Agency. Parents gave oral and written in-
formed consent.
Chemical analyses
Frozen samples were sent to the National Institute for
Health and Welfare, Department of Environmental Health
in Kuopio, Finland. Seventeen PCDD/F congeners, 37
PCB congeners, and 14 PBDE congeners (listed in Table 1)
were selected for the analyses. In the laboratory, samples
were defrosted and weighed. The weight of a single tissue
biopsy ranged from 0.043 to 0.78 g. The procedures to
extract, fractionate, and purify a sample and analyses by
high-resolution mass-spectrometer have been described in
detail previously [37–39]. Due to the small sample size it
was not possible to determine the fat content, and there-
fore concentrations are given as nano- or picograms per
gram sample. The case and control samples were analysed
in a randomly mixed order in seven batches and blinded
for the technician and chemist.
Recoveries of individual internal PCDD/F, PCB, and
PBDE standards were >60 %. Median limit of quantifi-
cation (LOQ) of a single congener was 1.3 pg/g (range:
0.06–14 pg/g) for tetra- to heptachlorinated and 8.8 pg/g
(range: 1.1–36 pg/g) for octachlorinated PCDD/F cong-
eners. For non-ortho-PCBs median LOQ was 1.0 pg/g
(range: 0.11–5.3 pg/g), and the median LOQ for mono-
and di-ortho-PCBs was 0.05 ng/g (range: 0.003–3.9 ng/g).
For PBDEs median LOQ was 0.048 ng/g (range:
0.003–2.9 ng/g). In the in-house fat control sample,
the relative standard deviations for the sum of
PCDD/Fs, the sum of PCBs, total-TEq, and the sum
of PBDEs were 3.3, 7.2, 13, and 8.9 %, respectively.
Procedural blank samples were analysed to monitor
laboratory and cross-sample contamination. The Finnish
Table 1 Persistent organic pollutants measured in the study
Persistent organic pollutants Congeners
Polychlorinated dibenzo-p-dioxins and
furans (PCDD/Fs)
2,3,7,8-TCDF, 2,3,7,8-TCDD, 1,2,3,7,8-PeCDF, 2,3,4,7,8-PeCDF, 1,2,3,7,8-PeCDF, 1,2,3,4,7,8-HxCDF,
1,2,3,6,7,8-HxCDF, 2,3,4,6,7,8-HxCDF, 1,2,3,7,8,9-HxCDF, 1,2,3,4,7,8-HxCDD, 1,2,3,6,7,8-HxCDD,
1,2,3,7,8,9-HxCDD, 1,2,3,4,6,7,8-HpCDF, 1,2,3,4,7,8,9-HpCDF, 1,2,3,4,6,7,8-HpCDD, OCDF, and OCDD
Polychlorinated biphenyls (PCBs) 18, 28/31, 33, 47, 49, 51, 52, 60, 66, 74, 77a, 81a, 99, 101, 105a, 110, 114a, 118a, 122, 123a, 126a, 128, 138, 141,
153, 156a, 157a, 167a, 169a, 170, 180, 183, 187, 189a, 194, 206, and 209
Polybrominated diphenyl ethers (PBDEs) 28, 47, 66, 71, 75, 77, 85, 99, 100, 119, 138, 153, 154, and 183
aPCDD/F-like PCB congener
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Accreditation Service, FINAS, has certified the laboratory
(T077) in performing PCDD/F, PCB, and PBDE analyses
in biological samples according to the EN ISO/IEC 17025
standard.
Statistics
The data was analysed with the R statistical package, ver-
sion 3.1.3 [40]. Values from the chemical analyses below
LOQ were treated as LOQ/2 and missing data as system
missing. Group differences in the incidence of gestational
diabetes, parity, and maternal smoking were tested with
Fischer’s exact test. Differences between groups in normally
distributed demographic variables were tested with ind-
ependent samples T-test (maternal age, total duration of
breastfeeding, duration of exclusive breastfeeding), with in-
dependent samples T-test after logarithmic transformation
(mothers’ weight before pregnancy, age at the operation),
or with Mann–Whitney U-test (previous breastfeeding,
length of gestation, birth weight).
Total-TEq and sums of PCBs, PCDD/Fs, and PBDEs
were calculated. Only TEq and sums were analysed to
avoid mass significance of multiple comparisons. Fur-
thermore, the concentrations of most chemicals within
one group correlated with each other (data not shown),
and it is therefore not possible to distinguish their indi-
vidual effects. Correlations between predictors and sum
of PCBs, sum of PCDD/Fs, and sum of PBDEs were tested
with Spearman’s rank correlation coefficient. Unadjusted
differences in chemical levels and TEqs between cases and
controls in Finland and Denmark were estimated with
independent samples T-test after logarithmic transform-
ation. Association between ln transformed levels of PCBs,
PCDD/Fs, and PBDEs and the risk of congenital crypt-
orchidism was assessed with a logistic regression analysis,
which also provided the odds ratios (ORs) i.e. the increase
of odds of cryptorchidism per multiplication of chemical
concentration with ca. 2.71 (Napier’s constant).
A two-stage testing strategy was chosen, in which first
the chemical concentrations were first adjusted for postna-
tal exposure by linear regression. Then the associations be-
tween the adjusted chemical concentrations and the risk of
congenital cryptorchidism were tested with an unadjusted
logistic regression, providing the ORs as in unadjusted ana-
lyses, but for chemical concentration which was not ex-
plained by duration of breastfeeding, age at the operation,
and country of origin.
The selection of the adjustment variables in the first stage
is shown in Fig. 1. According to a previous line of research,
the male reproductive development is programmed during
fetal life [8]. Therefore, we hypothesise that the exposure
before birth was causative, and the postnatal exposure was
not. Consequently, we aimed to minimise the variation in
the postnatal exposure by adjusting for the exposure via
breastfeeding [13–16], whereas the predictors of the
prenatal exposure were left unadjusted. Thus, ln trans-
formed chemical concentrations were adjusted for the age
when breastfeeding was discontinued, age at the operation,
and the country of origin in a linear regression model, but
not adjusted for maternal age or parity. Regression coeffi-
cients were transformed back from ln values to calculate a)
the relative increase (percentage) in chemical concentration
for each month of breastfeeding or higher age at operation
and b) the mean ratio of chemical concentrations in the
two countries (Denmark/Finland).
Previous studies suggest that gestational diabetes and
preterm birth may independently increase the risk of crypt-
orchidism [41–43], and may be related to the level of the
exposure at or before birth. Thus, the analyses were re-
peated excluding those children (11 cases, 12 controls),
who were born before gestational week 37 + 0, whose
mothers had gestational diabetes, or who were older than




Study sample characteristics are presented in Table 2.
Forty cases (11 Danish, 29 Finnish) and 33 controls (eight
Danish, 25 Finnish) had data from chemical measurements,
Fig. 1 Factors contributing to the prenatal and postnatal concentration
of chemicals and their relationship with the pathogenesis of congenital
cryptorchidism. Chemical concentrations in the analyses were adjusted
for total duration of breastfeeding and age at the operation to minimise
the variation in the postnatal exposure, which does not contribute to
the pathogenesis of congenital cryptorchidism. In contrast, factors
influencing the chemical concentrations in the mothers were not
adjusted for to maximise the likelihood to detect the association
between the chemical concentrations and the outcome
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duration of breastfeeding and age at the operation available
for the analyses. The mothers of the cryptorchid boys were
older than those of controls (p = 0.04), and had a longer
gestation (p = 0.04). There were no significant group differ-
ences in gestational diabetes, parity, maternal smoking,
total number of months the mother had breastfed in previ-
ous pregnancies, weight before pregnancy, birth weight, the
duration of exclusive breastfeeding, age when the breast-
feeding was discontinued, or age at operation. Four and
two boys in case and control group, respectively, were not
breastfed at all.
Levels of PCBs, PCDD/Fs, and PBDEs in adipose tissue
Concentrations of the total-TEq, and sums of PCBs,
PCDD/Fs, and PBDEs are shown in Table 3. Number
and percentage of individual PCB, PCDD/F, and PBDE
congeners above the LOQ are given in Additional file 1.
There were no differences between cases and controls in
the unadjusted chemical concentrations in either of the
countries. The sums of PCDD/Fs, PCBs, and total-TEq in
adipose tissue correlated positively with the total duration
of breastfeeding (rs = 0.58, p < 0.001; rs = 0.79 p < 0.001; and
rs = 0.78, p < 0.001, respectively), duration of exclusive
breastfeeding (rs = 0.51, p < 0.001; rs = 0.71, p < 0.001;
and rs = 0.68, p < 0.001, respectively), and maternal
age (rs = 0.28, p = 0.002; rs = 0.34, p = 0.01; and rs =
0.30, p = 0.007, respectively). The sum of PCBs and
total-TEq also correlated with the length of gestation
(rs = 0.28, p = 0.02 and rs = 0.31, p = 0.009, respe-
ctively), and the sum of PCBs with age at operation
(rs = 0.23, p = 0.03). The sum of PBDEs correlated posi-
tively only with parity and duration of previous breastfeed-
ing (rs = 0.36, p = 0.03 and rs = 0.40 p = 0.03, respectively).
Birth weight and mothers’ weight before pregnancy were
not associated with levels of PCBs, PCDD/Fs, PBDEs, or
total-TEq in adipose tissue.
The results of the linear regression analysis are presented
in Table 4. For each month of breastfeeding the levels of
total-TEq, sum of PCDD/Fs and sum of PCBs increased
with 13, 8, and 16 %. Duration of breastfeeding explained
48, 27, and 44 %, respectively, of the variation in the con-
centrations of total-TEq, sum of PCDD/Fs and sum of
PCB. Duration of breastfeeding did not correlate with the
sum of PBDEs in our model. When adjusting for breast-
feeding and age at the operation, Danish boys had 39 %
smaller sum of PCDD/Fs and 47 % smaller sum of PBDEs
than Finnish, whereas there were no significant differences
in the total-TEq or sum of PCBs. Age at the operation did
not correlate with any of the chemical concentrations,
Table 2 Study sample characteristics
Cases N (%)
or mean ± SD,
IQR
Controls N (%)






Total N 44 38
Gestational diabetes 8 (21 %) 4 (13 %) 5, 7 0.58
Parity 3, 1 0.24
0 23 (56 %) 15 (41 %)
1 7 (17 %) 13 (35 %)
2 9 (22 %) 6 (16 %)
3 2 (5 %) 3 (8 %)
Maternal smoking
during pregnancy
5 (18 %) 2 (9 %) 16, 16 0.47














39.4 ± 2.9, 38.2 ± 3.0, 6, 7 0.04*
38.8–41.0 37.6–40.6














2.3 ± 1.0, 2.9 ± 2.2, 0, 0 0.53
1.9–2.5 1.2–4.0
IQR Interquartile range. aFor the difference between cases and controls.
*Statistically significant (p < 0.05)
Table 3 Sums of PCBs, PCDD/Fs and PBDEs, and total-TEq in






Finland N = 30 N = 29
Sum of PCDD/Fs (pg/g) 113 (41.5–320) 77.7 (27.9–1290) 0.25
Sum of PCBs (ng/g) 68.9 (12.7–389) 80.0 (11.2–570) 0.97
Sum of PBDEs (ng/g) 7.01 (1.56–63.6) 5.41 (1.28–85.9) 0.42
Total-TEq (pg/g) 7.44 (3.24–40.7) 5.43 (2.65–64.1) 0.85
Denmark N = 14 N = 9
Sum of PCDD/Fs (pg/g) 88.9 (21.7–258) 83.0 (21.7–164) 0.83
Sum of PCBs (ng/g) 182 (17.4–698) 164 (12.8–517) 0.56
Sum of PBDEs (ng/g) 3.94 (1.56–31.0) 5.67 (3.54–9.43) 0.45
Total-TEq (pg/g) 18.5 (3.41–56.0) 13.0 (2.64–42.0) 0.73
Finland and Denmark N = 44 N = 38
Sum of PCDD/Fs (pg/g) 103 (21.7–320) 79.1 (21.7–1290) 0.94
Sum of PCBs (ng/g) 97.0 (12.7–698) 134 (11.2–570) 0.73
Sum of PBDEs (ng/g) 4.90 (1.56–63.6) 5.54 (1.28–85.9) 0.26
Total-TEq (pg/g) 9.78 (3.24–56.0) 7.50 (2.64–64.1) 0.55
aFor the difference between cases and controls
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when adjusting for duration of breastfeeding and coun-
try of origin.
Exposure to PCBs, PCDD/Fs and PBDEs and the risk of
cryptorchidism
The ORs with 95 % confidence intervals (95 % CI) for the
association between concentrations of PCBs, PCDD/Fs
and PBDEs and the risk of cryptorchidism are presented
in the Table 5. In the unadjusted logistic regression, there
were no significant associations. However, when adjust-
ing for the country of origin, age at operation and
the duration of breastfeeding, total-TEq (OR 3.21,
95 % CI 1.29–9.09, p = 0.02), and sum of PCDD/Fs
(OR 3.69, 95 % CI 1.45–10.9, p = 0.01) were associ-
ated with and an increased risk of cryptorchidism,
while the association of cryptorchidism with the sum
of PCBs was close to significant (OR 1.92, 95 % CI
0.98–4.01, p = 0.07). The sum of PBDEs was not associ-
ated with the risk of cryptorchidism (OR 0.86,
0.47—1.54, p = 0.61).
Estimates did not change substantially when the ana-
lyses were restricted to boys who were born term, oper-
ated at less than 5 years of age, and whose mothers did
not have gestational diabetes. In this sensitivity analysis,
levels of total-TEq (OR 3.47, 95 % CI 1.15–12.9, p = 0.04)
and sum of PCDD/Fs (OR 10.2, 95 % CI 2.36–65.5,
p = 0.005) were positively associated with the risk of
cryptorchidism, whereas sum of PCBs (OR 2.09,
95 % CI 0.82–6.04, p = 0.14) and sum of PBDEs (OR
0.80, 95 % CI 0.28–2.14, p = 0.64) were not.
Discussion
Our study showed that exposure to PCDD/Fs and
dioxin-like PCBs in adipose tissue increased the risk
of cryptorchidism. However, this finding became sta-
tistically significant only when the country of origin,
duration of breastfeeding and age at operation were
included in the statistical analyses controlling for post-
natal exposure. Furthermore, similar associations were
noted when the analyses were restricted to children who
were less than 5 years old at operation, born term, and
whose mothers did not have gestational diabetes.
The concentrations of PCBs and PCDD/Fs in adipose
tissue reflect the total cumulative exposure to these persist-
ent substances both before and after birth. Adipose tissue
biopsies were taken at the mean age of 2.3 and 2.9 years in
the case and control groups, respectively, and there was no
significant increase in the risk of cryptorchidism with
increasing absolute levels of the chemicals in that age.
However, as congenital cryptorchidism must arise from
prenatal exposure, we further refined our analyses by con-
trolling for variation in postnatal exposure. During the first
several months the children are predominantly exposed to
PCBs and PCDD/Fs via breast milk and later during child-
hood via ingestion of fatty foods [13, 14], and accordingly
duration of breastfeeding could explain 27–48 % of the
variation in the sums of PCBs and PCDD/Fs and total-TEq
in our study. Therefore, the concentrations were adjusted
for the difference of 1.3 months between cases and controls
in duration of breastfeeding, which resulted in a significant
Table 4 Adjustments for postnatal exposure to PCBs, PCDD/Fs and PBDEs using a multiple linear regression
Sum of PCDD/Fs Sum of PCBs Sum of PBDEs Total-TEq
Countrya β (95 % CI)b 0.61 (0.43–0.87) 1.20 (0.79–1.81) 0.53 (0.33–0.83) 1.13 (0.81–1.57)
p 0.006 0.38 0.007 0.46
R2 0.08 <0.01 0.10 <0.01
Duration of breastfeedinga β (95 % CI)c 1.08 (1.05–1.12) 1.16 (1.12–1.21) 1.01 (0.97–1.05) 1.13 (1.10–1.17)
p <0.001 <0.001 0.70 <0.001
R2 0.27 0.44 0.05 0.48
Age at the operationa β (95 % CI)d 1.00 (0.99–1.01) 1.00 (0.99–1.01) 1.01 (1.00–1.02) 1.00 (0.99–1.00)
p 0.73 0.83 0.27 0.27
R2 <0.01 <0.01 0.02 <0.01
aAltogether 40 cases and 33 controls. bRegression coefficients for the ratio of mean chemical concentrations in Danish versus Finnish subjects, adjusted for
duration of breastfeeding and age at the operation. cRegression coefficients for the relative increase in adjusted chemical concentrations per month of breastfeeding,
adjusted for country of origin and age at operation. dRegression coefficients for the relative increase in chemical concentrations per month of age at operation, adjusted
for country of origin and duration of breastfeeding
Table 5 ORs for the association between congenital








Sum of PCDD/Fs 1.41 (0.79–2.61) 0.25 3.69 (1.45–10.9) 0.01
Sum of PCBs 1.04 (0.70–1.54) 0.84 1.92 (0.98–4.01) 0.07
Sum of PBDEs 0.91 (0.53–1.55) 0.73 0.86 (0.47–1.54) 0.61
Total-TEq 1.17 (0.71–1.93) 0.54 3.21 (1.29–9.09) 0.02
aAltogether 44 cases and 38 controls. bAltogether 40 cases and 33 controls.
cAdjusted for the country of origin, age at operation, and age when breastfeeding
was discontinued. dFor the difference between cases and controls
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difference in the risk of cryptorchidism. The analyses were
also adjusted for country of origin and age at operation, but
this did not have a substantial influence on the results com-
pared to adjustment for duration of breastfeeding.
A child is predominantly exposed to PBDEs via breast-
feeding and diet, but in highly exposed individuals, the
exposure via dust and indoor air can represent up to 99 %
of the total exposure to some PBDE congeners [16]. This
substantial variation in the exposure via dust may explain
why the sum of PBDEs did not correlate with most of
the expected predictors in our study. Therefore, our
linear regression analysis may have lacked the statistical
power to find a correlation between the sum of PBDEs
and age at operation, or total duration of the breastfeed-
ing. Consequently, as highlighted by the small R2s of the
linear regression model, our model was not able to ad-
just for postnatal exposure to PBDEs and our finding
does not exclude the possibility of an association be-
tween cryptorchidism and exposure to PBDEs.
A recent study reported that persistent organic pollutant
concentrations measured at the age of 6–11 years corre-
lated poorly with maternal exposure levels, highlighting
that the exposure later during childhood may compromise
the assessment of the prenatal exposure [44]. However,
the concentration of some congeners did correlate
between mother and child even at that age, although the
correlation was weak [44]. In addition to the aforemen-
tioned adjustments for duration of breastfeeding, age at
operation, and country of origin, we took this into account
in the supplemental analysis by excluding the boys who
were older than 5 years when the fat biopsy was taken,
which provided similar results.
Mortamais and co-workers have previously used a simi-
lar statistical approach, in which the authors first con-
ducted a linear regression analysis adjusting for various
factors in sampling and based on the results calculated the
standardised chemical concentration under reference
sampling conditions [45]. In this study we similarly
adjusted for the variation with a linear regression and then
continued by relating this adjusted concentration to the
risk of cryptorchidism using logistic regression. However,
in this study we were primarily interested in the rela-
tionship between exposure to PCBs, PCDD/Fs and
PBDEs and congenital cryptorchidism instead of actual
chemical levels and therefore we merely used the resid-
uals of the first stage of analyses instead of the calcu-
lated estimate. The results of both studies suggest that
the adjustment for the variation introduced by sampling
conditions and the between-subject factors is necessary
especially with small sample sizes, and failure to do so
may result in significant associations being lost.
The mothers of the cryptorchid children were signifi-
cantly older than those of the control group, despite the
fact that they were both recruited randomly. This is in
agreement with previous studies that have identified ma-
ternal age as a risk factor of congenital cryptorchidism
[42, 43]. Interestingly, maternal age also correlated with
increased levels of PCBs and PCDD/Fs in their offspring,
which may contribute to the risk of cryptorchidism. We
argue that when studying the association between
congenital cryptorchidism and exposure to endocrine
disrupting chemicals, this kind of predictors of prenatal
exposure should not be adjusted for. Theoretically, if all
the predictors of prenatal exposure to endocrine disrupt-
ing chemicals between the mothers were known and
adjusted for, we would not find an association between
cryptorchidism and exposure to endocrine disrupting che-
micals even if there was a true relationship between the
two. However, if maternal age has an independent effect
on the pathogenesis of congenital cryptorchidism, which
is not a consequence of the age-related increase in the
body burden of the chemicals, it might explain some of
the observed association between cryptorchidism and
exposure to PCDD/Fs and PCDD/F-like PCBs.
To our knowledge, there is only one previous study
examining the association between cryptorchidism and
PCBs, PCDD/Fs, or PBDEs in adipose tissue biopsies.
That study did not have information on breastfeeding of
the boys and, similarly to our results, no association was
found between the sum of six PCB congeners (all non-
PCDD/F-like) and cryptorchidism in 18 cryptorchid
children and 30 controls [35].
There is evidence that increased occupational expos-
ure to dioxin-contaminated chlorophenol in a cohort of
9512 male saw mill workers between 1952 and 1988 was
associated with an increased risk of cryptorchidism in
their offspring [26]. Furthermore, in previous studies with
other biological matrices the mothers of cryptorchid chil-
dren in Denmark, but not in Finland, had higher sum of
14 PBDEs and WHO-TEq of 17 PCDD/Fs (no PCBs in-
cluded in WHO-TEq) in breast milk [27, 28]. However,
when the placental samples from Danish and Finnish
mothers were analysed, there were no differences between
cryptorchid and healthy children in the same groups of
chemicals [28, 30].
The evidence for an association between cryptorchidism
and exposure to PCBs appears weak. In a large US study
comparing serum samples of mothers of 230 boys with
cryptorchidism and 593 healthy children no association
between cryptorchidism and sum of 11 PCBs (two PCDD/
F-like, nine non-PCDD/F-like) could be demonstrated
when controlling for serum concentration of dichloro-
diphenyldichloroethylene (DDE) [32]. In addition, there
were no differences in the sum of 37 PCBs (12 PCDD/F-
like, 25 non-PCDD/F-like) in the aforementioned Danish-
Finnish study in which placentas from mothers of 56
Finnish and 39 Danish cryptorchid and 56 Finnish and
129 Danish healthy children were analysed [30].
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Furthermore, no difference was found in the sum of three
PCBs (all non-PCDD/F-like) in umbilical cord samples be-
tween 20 cases (19 cryptorchid children, one testicular
torsion) and 176 controls in the Faroe Islands [31].
Similarly, a French study found no statistically significant
differences between cases and controls in the median sum
of seven PCBs (one PCDD/F-like, six non-PCDD/F like) in
cord blood (67 cryptorchid and 84 healthy children) or in
breast milk from their mothers (mothers of 56 cryptorchid
and 69 healthy children) [29]. However, compared to con-
trols it was more common for cryptorchid children to have
maternal breast milk levels above the median of quantifi-
able values [29]. In the Danish-Finnish study examining 37
PCBs in breast milk, levels of several non-PCDD/F-like
congeners in breast milk of Danish subjects (29 crypt-
orchid cases, 36 controls) were associated with a decreased
risk of congenital cryptorchidism, whereas in the Finnish
subjects (33 cases, 32 controls) no such effect could be
demonstrated [27].
Taken together, these results indicate that the effect of
PCB exposure on the risk of cryptorchidism is too small
to be distinguished from the effects of the total back-
ground exposure to other endocrine disrupting chemi-
cals. However, this study and our previous results
indicate that exposure to PCDD/Fs accompanied by
PCDD/F-like PCBs that share the same toxicological
pathway may contribute to testicular maldescent.
There are some weaknesses in our study. Firstly, our
study is small and our control group included boys
with inguinal hernia, which has been associated with
cryptorchidism [42, 43]. However, since there are no
data to suggest that boys with inguinal hernia would be
less exposed than healthy children, it seems reasonable
to assume that this shortcoming decreases rather than
increases the chance of observing a group difference.
Furthermore, since both cases and controls were re-
cruited at departments of paediatric surgery, it is unsure
if the association between cryptorchidism and chemical
levels can be generalised to boys who have mild forms
of cryptorchidism, which does not require operation.
However, it is practically impossible to get inguinal
adipose tissue biopsies from boys who would not be
operated for a urogenital outcome on an ethically
sound basis. Secondly, as the children were recruited to
this study at various ages, our case group may include
children with acquired undescended testes, and our
control group may include boys with high scrotal testes
or congenital cryptorchidism with spontaneous postnatal
descent. Thirdly, we were not able to adjust for the
lipid content of the samples, which increases the meas-
urement error of the chemical concentrations. However,
since the samples were taken directly from the adipose
tissue, the variation in the lipid content should be
small. Fourthly, the Danish mothers were asked about
the duration of breastfeeding and obstetric data almost
10 years after the operation, which could raise questions
about the accuracy of the data. However, there is no
reason to believe that case or control group would re-
member the timing differently. Finally, we did not
gather data on body size of the children, which may in-
fluence chemical concentrations in tissue samples, and
thus increase the variance further. These limitations
may have reduced group differences between crypt-
orchid cases and controls.
Strengths of our study include the high number of the
PCB, PCDD/F and PBDE congeners analysed in the same
subjects. Furthermore, the boys who had cryptorchidism
were ‘true’ cases of cryptorchidism, since they were diag-
nosed both by the referring general practitioner and the
paediatric surgeon, and did not descend spontaneously be-
fore orchidopexy. In addition, our study included boys
from two countries, further increasing the generalizability
of the results.
Conclusions
Our study suggests that prenatal exposure to PCDD/Fs
and PCDD/F-like PCBs is associated with cryptorchid-
ism in humans. As there are geographical differences in
the exposure pattern to endocrine disrupting chemicals,
such association between cryptorchidism and the levels
of PCBs and PCDD/Fs in adipose tissue may vary between
different populations. The study cannot establish any causal
relationship, but it supports the hypothesis that exposure to
mixtures of endocrine disrupting chemicals may contribute
to the aetiology of congenital cryptorchidism. Levels of
PCBs and PCDD/Fs have declined substantially since
the 1970s, which however is not paralleled by a decli-
ning incidence of cryptorchidism. This suggests that
these chemicals are weak risk factors for cryptorchidism
or other environmental risk factors have emerged during
that window. Thus, PCBs and PCDD/Fs may represent a
sentinel for other persistent organic pollutants with simi-
lar exposure sources.
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